Order Article Reprints

Stergiou C, Williams R, Fleming JR, Zouvelou V, Ninou E, Andreetta F, Rinaldi E, Simoncini O, Mantegazza R, Bogomolovas J, et al. Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis. Biomedicines. 2023; 11(2):449. https://doi.org/10.3390/biomedicines11020449

Stergiou, Christos, Rhys Williams, Jennifer R. Fleming, Vasiliki Zouvelou, Elpinickie Ninou, Francesca Andreetta, Elena Rinaldi, Ornella Simoncini, Renato Mantegazza, Julius Bogomolovas, and et al. 2023. "Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis" Biomedicines 11, no. 2: 449. https://doi.org/10.3390/biomedicines11020449

Stergiou, C., Williams, R., Fleming, J. R., Zouvelou, V., Ninou, E., Andreetta, F., Rinaldi, E., Simoncini, O., Mantegazza, R., Bogomolovas, J., Tzartos, J., Labeit, S., Mayans, O., & Tzartos, S. (2023). Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis. Biomedicines, 11(2), 449. https://doi.org/10.3390/biomedicines11020449